Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts.
about
The corepressor CTBP2 is a coactivator of retinoic acid receptor/retinoid X receptor in retinoic acid signalingDifferential use of functional domains by coiled-coil coactivator in its synergistic coactivator function with beta-catenin or GRIP1The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppressionA novel isoform of human LZIP negatively regulates the transactivation of the glucocorticoid receptorEstradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and betaGlucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cellsResveratrol modulates the inflammatory response via an estrogen receptor-signal integration networkMinireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolismIdentification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta actionThe aryl hydrocarbon receptor complex and the control of gene expressionLigand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancyAn ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammationDeterminants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor.Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor.Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesMinireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GRSer484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation.Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor.Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression.Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor.Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor bindingGlucocorticoid receptor binds half sites as a monomer and regulates specific target genesMechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.Enhancer Turnover Is Associated with a Divergent Transcriptional Response to Glucocorticoid in Mouse and Human MacrophagesDistinct, genome-wide, gene-specific selectivity patterns of four glucocorticoid receptor coregulators.Transcriptional control of erythropoiesis: emerging mechanisms and principles.Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile.Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells.Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response.Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators.Drug discovery for inflammatory diseases.Kinetically-defined component actions in gene repressionSteroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapySTAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression.An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response.
P2860
Q24295243-1EB98E9D-8858-4225-A728-E2F5BB4481BAQ24298632-BFD6FA31-E3AD-4DD9-85DF-2A355EF20DF1Q24299196-D378EE82-08B5-42DF-8895-0E16B7D7FFB2Q24318529-A2A25A00-AF8E-46A0-912E-D0A32FBE8FD7Q24632806-0E309604-CB48-4751-ACF6-2B9C361E6B02Q24642399-D9FD5B07-30AF-4E25-8749-744DCD9767F4Q27683572-6683A608-2459-4B60-8D6F-3C20D4A1F001Q28084780-0059F9AA-04F6-4394-8A68-01E60D527F5BQ28155857-BFFB792A-8D71-4421-8565-A48B908985CDQ28386260-4B0610DC-4D01-4E57-911B-A33EB30CC461Q28568722-6C68C447-FF83-4637-8F3A-EFF36E5E2E01Q28593440-C4187043-BFEC-4A57-AC59-395BBD910991Q33287197-1DB660E7-355D-42E2-A97D-02732464E9F0Q33595368-A7946281-627B-4C10-A007-24439917066CQ33636430-4A02AC74-B840-45AC-9369-C1EE0196B2FDQ33636927-512EFEE8-E4C1-42FC-A0BF-47E1E1AEE7A7Q33642539-1BA4D7D3-44C7-4E68-8A8A-27843E4906DEQ33658906-3051AB9F-D418-4D04-8D87-B7F96236A698Q33670499-8C2BEEB4-4F13-4723-AA34-0438D4A77632Q33713336-016E0820-7438-4FFD-9F05-2B548602A133Q33756323-DE576A91-BA71-44EE-84A5-90BBAFCEE56EQ33780734-DDCC0AFD-75B0-4B21-A7E9-0FCC772A81A5Q33874323-5FA2DE4D-C385-4F1B-8A0D-9089CC57ABBAQ33928526-90AE5F2C-9666-4536-B0A4-0E927EB404C5Q33950182-7A950583-BB4D-43B3-A95C-571AE6ECB594Q34109185-0899CC29-68FD-4A73-96AE-5AA779C94611Q34392493-B89ECB4B-D323-4959-846D-097201CEF9A8Q34458338-818100E4-FFEA-4643-AFA7-A5E32DF85DB8Q34505002-1B40B3C7-43D3-4599-87C8-4C8FC20C04C1Q34564788-F2A849F0-ED4D-41C7-9863-B256B32FE3DAQ34700755-CE3C2B7B-9C13-4F53-81F5-233316C8CF11Q34717142-EDA9D0BC-9ACD-41C9-8CAA-5AD49E0E3348Q34921964-CE3F8E74-E9F7-486F-A926-7E31361B1AAFQ35010893-87952294-1D42-4E67-9207-7BD6156DEDE3Q35113556-D2691A08-15E0-4DBD-B8E3-1F9C4C4D64FEQ35207540-B7F78569-E23F-4117-BE92-D12BC0BDE925Q35223752-711C7A71-6706-42C9-A858-C07358DBA785Q35456938-FE1EE4ED-FDE7-48F1-A204-B25C7AE9A352Q35641879-4C6143E7-0B05-46CF-93F9-27727DBE0FA6Q35781606-5BBF5F46-F5FF-407B-8EE4-3F789240D024
P2860
Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Alternate surfaces of transcri ...... ation and repression contexts.
@ast
Alternate surfaces of transcri ...... ation and repression contexts.
@en
Alternate surfaces of transcri ...... ation and repression contexts.
@nl
type
label
Alternate surfaces of transcri ...... ation and repression contexts.
@ast
Alternate surfaces of transcri ...... ation and repression contexts.
@en
Alternate surfaces of transcri ...... ation and repression contexts.
@nl
prefLabel
Alternate surfaces of transcri ...... ation and repression contexts.
@ast
Alternate surfaces of transcri ...... ation and repression contexts.
@en
Alternate surfaces of transcri ...... ation and repression contexts.
@nl
P2093
P2860
P356
P1476
Alternate surfaces of transcri ...... ation and repression contexts.
@en
P2093
Dale C Leitman
Inez Rogatsky
Keith R Yamamoto
P2860
P304
16701-16706
P356
10.1073/PNAS.262671599
P407
P50
P577
2002-12-12T00:00:00Z